Monocular Compound Microscope

All about monocular compound microscope
Monocular Compound Microscope Resources

Home > Monocular Compound Microscope > DAILY RFID Launches 13.56MHz HF RFID Handheld reader writer DL8033

DAILY RFID Launches 13.56MHz HF RFID Handheld reader writer DL8033




DAILY RFID (www.rfid-in-china.com ), a fast growing company with unique expertise in RFID tag and RFID reader, has recently launched HF RFID Handheld Reader/writer DL8033 designed for industrial and outdoor environments. This 13.56MHz PDA based RFID reader/write provides a very good stability in any environment with a low price at 850USD.

The DAILY RFID Handheld Reader is a small, lightweight Reader used to find tagged items quickly and conveniently.The RFID Handheld Reader, fits comfortably in the palm of your hand. Users carry this handheld reader while looking for specific items such as merchandise, inventory, or other assets.

This RFID handheld reader has multi-protocol capability and also support GPRS Voice and Data transfer, support Bluetooth 1.1 standard and various physical layer communication interfaces.

Please visit http://www.rfid-in-china.com/products_701_1.html for more infomation about RFID Handheld reader.

About DAILY RFID CO.,LIMITED

DAILY RFID CO.,LIMITED , which belongs to PAN Group Co., ltd, is the leading company focusing on the research and development of EPC & RFID technology in China.

DAILY RFID specialize in producing arguably the world's most extensive line of RFID Tag,RFID Label,Smart Card and RFID Reader, which are suitable for any vertical markets, and have obtained the National Integrated Circuit Card Register Certificate, IC Card Manufacture License and ISO9001 Quality Management System Certification. Also, we own a factory covering an area of 26,000 square meters.

DAILY's products are designed and manufactured with recognized industry standards relevant to RFID and its markets but most notably for use in the demanding environments to recognize and understand your business's RFID needs. We are commited to providing "Innovative Technology", " Superior, Cost-efficient Product" and " Professional, Efficient Customer Services".


Click Here to read the entire article...




Other Articles:


Material witness: A twisted tale
Click Here to read the entire article...
Mending Broken Hearts With Tissue Engineering
Broken hearts could one day be mended using a novel scaffold. The new scaffold approach could also aid the engineering of other tissues.
Click Here to read the entire article...
US Oxygen Policy A Disaster For Suppliers, Says National Association Of Independent Medical Equipment Suppliers
After three years waiting for the post 36-month capped oxygen policy, the DME industry received a stark dose of CMS unreality. In just 22-pages of the 1459 page final rule for the Medicare Physician Fee Schedule (MPFS) for calendar year 2009, CMS took the mandate of Congress in the DRA 2005 and MIPAA 2008 to the very extremes.
Click Here to read the entire article...
Senesco's Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics'
Click Here to read the entire article...
Researcher Grows Roots On Upper Part Of Plant
Researchers have succeeded in growing roots on plants at places where normally leaves would grow. This important step in plant modification can be highly beneficial for improving crop yields and efficiency in agriculture.
Click Here to read the entire article...
Dr. Charis Eng, Chair and Founding Director, Genomic Medicine Institute, Cleveland Clinic Foundation, and Professor and Vice Chairman, Department of Genetics, Case Western Reserve University School of Medicine, 8-9-07
Genomic medicine, genetic counseling, PTEN, breast cancer research. Dr. Charis Eng's research interests may be broadly characterized as clinical cancer genetics translational research. Dr. Eng has published over 230 peer-reviewed original papers in such journals as the New England Journal of Medicine, Lancet, and Nature. She is a Fellow of AAAS and recipient of the Doris Duke Distinguished Clinical Scientist Award. Dr. Eng will serve a four-year term on the Board of Scientific Directors of the National Human Genome Research Institute beginning in Fall 2007.
Click Here to read the entire article...
Make - All Discussions
By editors@medicalnewstoday.com (MNT Editors) - Copyright 2008 Medical News Today - version: v1.5 build A